Skip to main content
Tuesday
April 14, 2026
Sign In
Subscribe
Latest
Economy
Banking
Stocks
Industry
Analysis
Bazaar
RMG
Corporates
Aviation
Videos
TBS Today
TBS Stories
TBS World
News of the day
TBS Programs
Podcast
Editor's Pick
World+Biz
Features
Panorama
The Big Picture
Pursuit
Habitat
Thoughts
Splash
Mode
Tech
Explorer
Brands
In Focus
Book Review
Earth
Food
Luxury
Wheels
Subscribe
Get the Paper
Epaper
GOVT. Ad
More
Sports
TBS Graduates
Bangladesh
Supplement
Infograph
Explainer
Archive
Gallery
Long Read
Interviews
Offbeat
Magazine
Climate Change
Health
Cartoons
বাংলা
TUESDAY,
APRIL 14, 2026
CureVac
CureVac
Covid vaccine from Germany's CureVac just 48% effective: final results
The European Union has secured up to 405 million doses of the CureVac vaccine
CureVac crashes after crucial Covid-19 vaccine trial disappoints
CureVac says mass vaccine rollout thrown into doubt by US restrictions
CureVac starts review process in Switzerland for Covid-19 vaccine hopeful
CureVac's Covid-19 vaccine attracts rising interest
CureVac says aiming for pivotal vaccine trial read-out early in Q2
CureVac says preliminary trials show Covid-19 vaccine effective against variants
GSK, CureVac say to develop vaccine targeting Covid variants
Bayer and Rentschler to help produce CureVac's Covid-19 shot
Bayer aims to help CureVac with Covid-19 vaccine output, says CEO
CureVac strikes Covid-19 vaccine alliance with Bayer
EU could pay over $10 billion for Pfizer and CureVac vaccines
CureVac hiking capacity to 300 million Covid-19 doses in 2021
Show More